A cooperative community: defining how the microbiome shares vitamin B12 for mutual benefit

24th June 2021

Researchers from the Quadram Institute are launching a new project to uncover how bacteria in the gut microbiome make and use vitamin B12. By better understanding the role of this essential micronutrient in the complex microbial community, they hope to be able to find new ways of improving the gut microbiome, ultimately benefitting our health.

The gut microbiome consists of trillions of microbes that interact with each other and the gut lining We are starting to understand how the makeup of that complex community and the nature of those interactions define how the microbiome affects the health of its host – us. Using this knowledge, we can find ways of manipulating the microbiome to optimise its health benefits.

Ruminococcus gnavus (green) in the mucus layer (red) of the gut lining (gut cell nuclei are blue). Image by Laura Vaux, Juge Group, the Quadram Institute

Ruminococcus gnavus (green) in the mucus layer (red) of the gut lining (gut cell nuclei are blue). Image by Dr Laura Vaux, Juge Group, the Quadram Institute

What is crucial to this is not just the species of bacteria, but also how they interact, including how different species share resources between different members of the community, for mutual benefit.

One such resource is vitamin B12. It is critical for fundamental processes in bacterial cell, making it a valuable resource within the microbiome. However, very few bacteria can make it – it’s a large molecule that has a complicated synthesis process that takes up a lot of energy. But those bacteria that can make it have a significant growth advantage, as will any other species that they share it with. But what is the nature of that trade off?

This is the question Professors Nathalie Juge and Martin Warren will answer in this new study, supported by a £500,000 grant from the Biotechnology and Biological Sciences Research Council, part of UK Research & Innovation (UKRI).

Prof. Juge is a world-leading expert in gut microbes and their interactions with the glycan-rich mucus that line the gut. In the work leading to this project, they found that Ruminoccus gnavus, one the model organisms they work with in the lab to study mucin glycan utilisation, needs vitamin B12 to grow whereas strains of Limosilactobacillus reuteri (previously called Lactobacillus reuteri) that are found in the human gut could make vitamin B12. The team has now shown in experiments that growth of R. gnavus can be rescued if L.reuteri is present.

They will collaborate with Quadram colleagues working with Professor Martin Warren, an expert in the biochemistry of vitamin B12 to understand how vitamin B12 is central to their interdependency, and how that benefits us. Martin leads Quadram’s Food Innovation and Health programme.

Nathalie JugeProf Juge said ‘I am delighted to be working together with Prof Martin Warren on Vitamin B12 interdependency by two of the model organisms, L. reuteri and R. gnavus we work on in our lab. This collaborative project will allow us to work across programmes to provide chemical and biochemical answers to how bacteria have evolved their complex trade-offs by sharing metabolic burden. We will also exploit these findings to design B12-based strategies to manipulate microbial composition in the gut for the benefit of human health.’

The new project will define the details of this relationship, by working out precisely how L. reuteri synthesises vitamin B12, the exact form of the vitamin it produces, and how R. gnavus then takes up and metabolises it. With this knowledge, the team will then test how well different interventions work in advanced models of the human colon, seeded with human microbiome samples containing little or no vitamin B12. They will compare supplementation with various forms of vitamin B12 alongside addition of B12-producing L. reuteri strains, looking at how well they support a healthy microbiome.

It is hoped that this study will lead to ways that we can all maintain our microbiome to maximise its benefits to health, as well as developing targeted new treatments for specific conditions linked to low B12 status. People with pernicious anaemia, for example, may benefit as they have an impaired ability to absorb B12 from the diet. Plants don’t produce B12, meaning vegans and vegetarians may risk getting insufficient B12 so this project may open up new ways of supporting plant-based diets for maximum gut health.

Related Targets

Targeting the understanding of the microbiome

Understanding the Microbiome

Targeting personalised nutrition

Personalised Nutrition

Targeting Future Foods

Future Foods

Related Research Groups

Martin Warren

Juge group

Nathalie Juge

Related Research Areas